These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28622854)
21. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice. Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017 [TBL] [Abstract][Full Text] [Related]
22. Immune Correlates of Protection Induced by Virus-Like Particles Containing 2009 H1N1 Pandemic Influenza HA, NA or M1 Proteins. Moon EK; Kang HJ; Chu KB; Lee SH; Lee DH; Soh Y; Quan FS Immunol Invest; 2019 May; 48(4):355-366. PubMed ID: 30430891 [TBL] [Abstract][Full Text] [Related]
23. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins. Ze C; Kurata T; Tamura S Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019 [TBL] [Abstract][Full Text] [Related]
24. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. Pillet S; Kobasa D; Meunier I; Gray M; Laddy D; Weiner DB; von Messling V; Kobinger GP Vaccine; 2011 Sep; 29(39):6793-801. PubMed ID: 21211587 [TBL] [Abstract][Full Text] [Related]
25. Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes. Tan L; Lu H; Zhang D; Tian M; Hu B; Wang Z; Jin N Virol J; 2010 Dec; 7():363. PubMed ID: 21134292 [TBL] [Abstract][Full Text] [Related]
26. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000 [TBL] [Abstract][Full Text] [Related]
27. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989 [TBL] [Abstract][Full Text] [Related]
28. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483 [TBL] [Abstract][Full Text] [Related]
29. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Kadowaki S; Chen Z; Asanuma H; Aizawa C; Kurata T; Tamura S Vaccine; 2000 Jun; 18(25):2779-88. PubMed ID: 10812219 [TBL] [Abstract][Full Text] [Related]
30. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus. Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505 [TBL] [Abstract][Full Text] [Related]
31. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Scott VL; Patel A; Villarreal DO; Hensley SE; Ragwan E; Yan J; Sardesai NY; Rothwell PJ; Extance JP; Caproni LJ; Weiner DB Hum Vaccin Immunother; 2015; 11(8):1972-82. PubMed ID: 26091432 [TBL] [Abstract][Full Text] [Related]
32. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge. Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene. Operschall E; Pavlovic J; Nawrath M; Mölling K Intervirology; 2000; 43(4-6):322-30. PubMed ID: 11251388 [TBL] [Abstract][Full Text] [Related]
35. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102 [TBL] [Abstract][Full Text] [Related]
36. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice. Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590 [TBL] [Abstract][Full Text] [Related]
38. Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice. Meng S; Liu Z; Xu L; Li L; Mei S; Bao L; Deng W; Li L; Lei R; Xie L; Qin C; Zhang L PLoS One; 2011; 6(5):e19863. PubMed ID: 21625486 [TBL] [Abstract][Full Text] [Related]
39. DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza. Williman J; Young S; Buchan G; Slobbe L; Wilson M; Pang P; Austyn J; Preston S; Baird M Vaccine; 2008 Sep; 26(40):5153-8. PubMed ID: 18456374 [TBL] [Abstract][Full Text] [Related]